Anti-psychotics adherence among out-patients with schizophrenia in Hong Kong

Keio Journal of Medicine

Volumn 55, Issue 1, 2006, Pages 9-14

  Hui, Christy L M ^a   Chen, Eric Y H ^a   Kan, C S ^c   Yip, K C ^d   Law, C W ^b   Chiu, Cindy P Y ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

^c CASTLE PEAK HOSPITAL   (Hong Kong)

^d KOWLOON HOSPITAL   (Hong Kong)

Author keywords

Compliance; Medication adherence; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; ATTITUDE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HONG KONG; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PATIENT DECISION MAKING; PERCEPTION DISORDER; QUESTIONNAIRE; SCHIZOPHRENIA; SELF REPORT; SEX DIFFERENCE; SUBSTANCE ABUSE;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; SCHIZOPHRENIA;

EID: 33646577190     PISSN: 00229717     EISSN: 00229717     Source Type: Journal    
DOI: 10.2302/kjm.55.9     Document Type: Article

References (27)

1. Sabaté E: Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003
2. Fenton WS, Blyler CR, Heinssen RK: Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr Bull 1997; 23: 637-651
3. Dolder CR, Lacro JP, Leckband S, Jeste DV: Interventions improve antipsychotic medication adherence: review of recent literature. J Clin Psychopharmacol 2003; 23: 389-399
4. Coldham EL, Addington J, Addington D: Medication adherence of individuals with a first episode of psychosis. Acta Psychiatr Scand 2002; 106: 286-290
5. Bebbington PE: The content and context of compliance. Int Clin Psychopharmacol 1995; 9 Suppl 5: 41-50
6. Dixon LB, Lehman AF: Family interventions for schizophrenia. Schizophr Bull 1995; 21: 631-643
7. Agarwal MR, Sharma VK, Kishore Kumar KV, Lowe D: Non-compliance with treatment in patients suffering from schizophrenia: a study to evaluate possible contributing factors. Int Soc Psychiatry 1998; 44: 92-106
8. Kampman O, Laippala P, Vaananen J, Koivisto E, Kiviniemi P, Kilkku N, Lehtinen K: Indicators of medication compliance in first-episode psychosis. Psychiatry Res 2002; 110: 39-48
9. Hudson TJ, Owen RR, Thrush CR, Han X, Pyne JM, Thapa P, Sullivan G: A pilot study of barriers to medication adherence in schizophrenia. J Clin Psychiatry 2004; 65: 211-216
10. Knapp M: Schizophrenia costs and treatment cost-effectiveness. Acta Psychiatr Scand Suppl 2000; 407: 15-18
11. O'Donnell C, Donohoe G, Sharkey L, Owens N, Migone M, Harries R, Kinsella A, Larkin C, O'Callaghan E: Compliance therapy: a randomised controlled trial in schizophrenia. BMJ 2003; 327: 834
12. Kemp R, Kirov G, Everitt B, Hayward P, David A: Randomised controlled trial of compliance therapy. 18-month follow-up. Br J Psychiatry 1998; 172: 413-419
13. Thompson K, Kulkarni J, Sergejew AA: Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res 2000; 42: 241-247
14. Nageotte C, Sullivan G, Duan N, Camp PL: Medication compliance among the seriously mentally ill in a public mental health system. Soc Psychiatry Psychiatr Epidemiol 1997; 32: 49-56
15. Fleischhacker WW, Oehl MA, Hummer M: Factors influencing compliance in schizophrenia patients. J Clin Psychiatry 2003; 64 Suppl 16: 10-13
16. Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV: Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry 2002; 63: 892-909
17. Buchanan A: A two-year prospective study of treatment compliance in patients with schizophrenia. Psychol Med 1992; 22: 787-797
18. Donohoe G, Owens N, O'Donnell C, Burke T, Moore L, Tobin A, O'Callaghan E: Predictors of compliance with neuroleptic medication among inpatients with schizophrenia: a discriminant function analysis. Eur Psychiatry 2001; 16: 293-298
19. Ruscher SM, de Wit R, Mazmanian D: Psychiatric patients' attitudes about medication and factors affecting noncompliance. Psychiatr Serv 1997; 48: 82-85
20. Novak-Grubic V, Tavcar R: Predictors of noncompliance in males with first-episode schizophrenia, schizophreniform and schizoaffective disorder. Eur Psychiatry 2002; 17: 148-154
21. Budd RJ, Hughes IC, Smith JA: Health beliefs and compliance with antipsychotic medication. Br J Clin Psychol 1996; 35: 393-397
22. Garavan J, Browne S, Gervin M, Lane A, Larkin C, O'Callaghan E: Compliance with neuroleptic medication in outpatients with schizophrenia; relationship to subjective response to neuroleptics; attitudes to medication and insight. Compr Psychiatry 1998; 39: 215-219
23. Flaskerud JH, Hu LT: Relationship of ethnicity to psychiatric diagnosis. J Nerv Ment Dis 1992; 180: 296-303
24. Lindstrom E, Bingefors K: Patient compliance with drug therapy in schizophrenia. Economic and clinical issues. Pharmacoeconomics 2000; 18: 106-124
25. Diaz E, Neuse E, Sullivan MC, Pearsall HR, Woods SW: Adherence to conventional and atypical antipsychotics after hospital discharge. J Clin Psychiatry 2004; 65: 354-360
26. Menzin J, Boulanger L, Friedman M, Mackell J, Lloyd JR: Treatment adherence associated with conventional and atypical antipsychotics in a large state Medicaid program. Psychiatr Serv 2003; 54: 719-723
27. Loffler W, Kilian R, Toumi M, Angermeyer MC: Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment. Pharmacopsychiatry 2003; 36: 105-112